ログイン

Good Compounding Practices and Techniques
69問 • 5ヶ月前
  • HERSHEY VALERIE BERNARDINO
  • 通報

    問題一覧

  • 1

    Study that concern itself with the physical, chemical, and biological factors which influenced the formulation, manufacture, stability, and effectiveness of pharmaceutical dosage forms

    Pharmaceutics

  • 2

    An agent intended for use in diagnosis, mitigation, treatment, cure, and prevention of disease in man or animal

    Drug

  • 3

    Dosage forms in which drugs are prepared by the pharmacists for administration in the treatment of disease

    Pharmaceutical preaparations

  • 4

    This may be done extemporaneously compounded or manufactured for immediate distribution

    Pharmaceutical preparations

  • 5

    Dosage forms are also known as

    Pharmaceuticals

  • 6

    It is prepared by adding an active ingredient (API / therapeutic ingredients / pharmacological active ingredients ) and a non-therapeutic ingredient (inert or inactive ingredients) which comprises a vehicle or formulation matrix

    Dosage forms

  • 7

    Other term for non-therapeutic / inert / inactive ingredients

    excipients

  • 8

    Means the production, preparation, propagation, conversion, or processing of a drug or device, either directly or indirectly, by extraction from substances of natural origin or independently by means of chemical or biological synthesis

    Manufacturing

  • 9

    Preparation of components into a drug product as the result of a practitioner's prescription drug order based on the practitioner/patient/pharmacist relationship in the course of professional practice

    Compounding

  • 10

    Preparation of components into a drug product for the purpose of, or as an incident to, research, teaching, or chemical analysis and not for sale or dispensing

    Compounding

  • 11

    What compedium chap. 795 stated that compounding is the preparation, mixing, assembling, altering, packaging and labeling of a drug, drug delivery device, or device in accordance with a licensed practitioner’s prescription, medication order, or initiative based on the practitioner-patient-pharmacist-compounder relationship in the course of professional practice

    United States Pharmacopeia

  • 12

    Pharmacists may _____, in reasonable quantities, dmg preparations that are commercially available in the marketplace if a pharmacist-patient-prescriber relationship exists and a valid prescription is presented

    compound

  • 13

    Pharmacists may compound _____ medications in commercially available dosage forms or in alternative dosage forms to accommodate patient needs as allowed by individual state boards of pharmacy

    non prescription

  • 14

    Pharmacists may _____ drugs in limited quantities prior to receiving a valid prescription, on the basis of a history of receiving valid prescriptions that have been generated solely within an established pharmacist-patient–prescriber relationship, and provided that the prescriptions are maintained on file for all such preparations dispensed at the pharmacy

    compound

  • 15

    Pharmacists should not offer _____ medications to other pharmacies for resale; however, a practitioner may obtain compounded medication to administer to patients, but it should be labeled with the following: “For Office Use Only,” date compounded, use-by date, and name, strength, and quantity of active ingredients. An exception to this may be the outsourcing of some compounded preparations by hospitals to contract compounding pharmacies

    compounded

  • 16

    _____ pharmacies and pharmacists may advertise or otherwise promote the fact that they provide prescription compounding services

    Compounding

  • 17

    It is devised to make possible the administration of medication in measured prescribed amount

    Dosage forms

  • 18

    Device that holds a drug and is or may be, in direct contact with the drug

    Containers

  • 19

    In direct contact with the drug at all times; e.g. closure

    Immediate container

  • 20

    It protects the content from extraneous solids and from loss of the article under ordinary conditions of handling, shipment, storage, and distribution

    Well closed container

  • 21

    It protects the contents from contamination by extraneous liquids, solids, or vapors, from loss of the article and from efflorescence, deliquescence, or evaporation under the ordinary or customary conditions of handling, shipment, storage, and distribution, and is caple of tight reclosure

    Tightly closed container

  • 22

    it is impervious to air or any other gas under the ordinary or customary conditions of handling, shipment, storage, and distribution

    Hermetic container

  • 23

    Intended for injection or parenteral preparation

    Hermetic container

  • 24

    Known as unit dosage package

    Single dose container

  • 25

    One that holds a quantity of drug intended and cannot be resealed when opened with assurance that sterility has been maintained

    Single dose container

  • 26

    One that contains more dose of the medication and permits the withdrawal of successive portions without changing the strength or endangering the quality or purity of the remaining portion

    Multiple dose container

  • 27

    Used primarily for liquid dosage forms

    Round bottle

  • 28

    Used for dispensing liquids of low viscosity

    Rx bottle

  • 29

    Used for bulk powders or large quantity of tablets or capsules

    Wide mouth bottle

  • 30

    Used for applying liquid medication to a wound or skin surface

    Application bottle

  • 31

    Used for powders to be applied by sprinkle

    Sifter-top containers

  • 32

    Used for ophtalmic and otic preparation

    Dropper bottle

  • 33

    Used to dispense semi-solid dosage forms (2 answers)

    Ointment jar, Collapsible tube

  • 34

    Used to dispense liquid contents as a mist or foam

    Aerosol container

  • 35

    Labelling includes desired condition to ensure the stability of a pharmaceutical preparation for the period of its intended shelf life

    Storage

  • 36

    Storage condition hot exceeding 8°C

    Cold

  • 37

    Storage condition between 8-15°C

    Cool

  • 38

    Temperature prevailing in working area

    Room temperature

  • 39

    Storage condition between 15-30°C

    Controlled room temp

  • 40

    Storage condition between 30-40°C

    Warm temp

  • 41

    Storage condition above 40°C

    Excessive heat

  • 42

    Refers to the length of time that a drug produced may remain on the pharmacist’s shelf in the original packages and under usual environmental condition

    Shelf life

  • 43

    Retain an acceptable level of its original potency and overall quality

    Shelf life

  • 44

    If storage condition are not met, either physical degradation or chemical deterioration may occur

    Shelf life

  • 45

    Latest date at which the product is expected to be stable physically, chemically, therapeutically, identity, strength, quality, and purity until that date if storage condition are met

    Expiry date / Beyond Use date

  • 46

    Manufacturer's shelf life of solid dosage forms (e.g. tab & cap)

    5 years from the date of preparation

  • 47

    Manufacturer's shelf life of liquid dosage forms

    shorter shelf life

  • 48

    Manufacturer's shelf life of dispersed systems-aerosols, emulsions, and semi-solid (eg. ointments & suppositories)

    shorter shelf life

  • 49

    Extemporaneous compounding shelf life of non-preserved aqueous

    14 days

  • 50

    Extemporaneous compounding shelf life of preserved aqueous

    35 days

  • 51

    Extemporaneous compounding shelf life of nonaqueous dosage forms

    90 days

  • 52

    Extemporaneous compounding shelf life of solid dosage forms

    180 days

  • 53

    Nomenclature of drug's proprietary name

    brand name

  • 54

    Nomenclature of drug's proprietary name

    trade name

  • 55

    Nomenclature of drug's non-proprietary name

    generic name

  • 56

    Uses yellow prescription

    Dangerous drugs

  • 57

    Prohibited and regulated drugs

    Dangerous drugs

  • 58

    Prescription or legend drugs are also called _____ drugs

    ethical

  • 59

    Requires Rx label

    Prescription / Legend drugs

  • 60

    Can be bought w/o prescription

    OTC drugs

  • 61

    Swallowing via mouth

    per oral

  • 62

    Injected into the body

    parenteral

  • 63

    Inserted into the rectum

    rectal

  • 64

    Applied to a certain area of the skin

    topical

  • 65

    Inserted into the vagina

    vaginal

  • 66

    Inhaled through mouth or nose

    inhalation

  • 67

    Under the tongue

    oral-sublingual

  • 68

    Beside the cheek

    oral-buccal

  • 69

    Administered by application to the tongue

    oral-perlingual

  • M#5 Section and Title v2

    M#5 Section and Title v2

    ユーザ名非公開 · 32問 · 13日前

    M#5 Section and Title v2

    M#5 Section and Title v2

    32問 • 13日前
    ユーザ名非公開

    MPLE

    MPLE

    ユーザ名非公開 · 41問 · 13日前

    MPLE

    MPLE

    41問 • 13日前
    ユーザ名非公開

    Weekly Test 3

    Weekly Test 3

    ユーザ名非公開 · 50問 · 13日前

    Weekly Test 3

    Weekly Test 3

    50問 • 13日前
    ユーザ名非公開

    Weekly Test 2

    Weekly Test 2

    ユーザ名非公開 · 50問 · 13日前

    Weekly Test 2

    Weekly Test 2

    50問 • 13日前
    ユーザ名非公開

    Refresher SPDI 1

    Refresher SPDI 1

    ユーザ名非公開 · 9問 · 13日前

    Refresher SPDI 1

    Refresher SPDI 1

    9問 • 13日前
    ユーザ名非公開

    Refresher SPDI 1

    Refresher SPDI 1

    ユーザ名非公開 · 100問 · 13日前

    Refresher SPDI 1

    Refresher SPDI 1

    100問 • 13日前
    ユーザ名非公開

    Definition of Terms 3

    Definition of Terms 3

    ユーザ名非公開 · 90問 · 13日前

    Definition of Terms 3

    Definition of Terms 3

    90問 • 13日前
    ユーザ名非公開

    Definition of Terms 2

    Definition of Terms 2

    ユーザ名非公開 · 90問 · 13日前

    Definition of Terms 2

    Definition of Terms 2

    90問 • 13日前
    ユーザ名非公開

    Definition of Terms 1

    Definition of Terms 1

    ユーザ名非公開 · 90問 · 13日前

    Definition of Terms 1

    Definition of Terms 1

    90問 • 13日前
    ユーザ名非公開

    WT 6

    WT 6

    ユーザ名非公開 · 50問 · 13日前

    WT 6

    WT 6

    50問 • 13日前
    ユーザ名非公開

    WT 3

    WT 3

    ユーザ名非公開 · 50問 · 13日前

    WT 3

    WT 3

    50問 • 13日前
    ユーザ名非公開

    SPI version D pt 2

    SPI version D pt 2

    ユーザ名非公開 · 61問 · 13日前

    SPI version D pt 2

    SPI version D pt 2

    61問 • 13日前
    ユーザ名非公開

    RNPCP Chapter 6 to 9

    RNPCP Chapter 6 to 9

    ユーザ名非公開 · 94問 · 13日前

    RNPCP Chapter 6 to 9

    RNPCP Chapter 6 to 9

    94問 • 13日前
    ユーザ名非公開

    Item 303 Bituminous Seal Coat

    Item 303 Bituminous Seal Coat

    ユーザ名非公開 · 20問 · 13日前

    Item 303 Bituminous Seal Coat

    Item 303 Bituminous Seal Coat

    20問 • 13日前
    ユーザ名非公開

    Item 301 Bituminous Prime Coat

    Item 301 Bituminous Prime Coat

    ユーザ名非公開 · 10問 · 13日前

    Item 301 Bituminous Prime Coat

    Item 301 Bituminous Prime Coat

    10問 • 13日前
    ユーザ名非公開

    Item 300 Aggregate Surface Course

    Item 300 Aggregate Surface Course

    ユーザ名非公開 · 11問 · 13日前

    Item 300 Aggregate Surface Course

    Item 300 Aggregate Surface Course

    11問 • 13日前
    ユーザ名非公開

    Item 206 Chemically Stabilized Road Mix Subbase/Base Course

    Item 206 Chemically Stabilized Road Mix Subbase/Base Course

    ユーザ名非公開 · 11問 · 13日前

    Item 206 Chemically Stabilized Road Mix Subbase/Base Course

    Item 206 Chemically Stabilized Road Mix Subbase/Base Course

    11問 • 13日前
    ユーザ名非公開

    Item 207 Portland Cement Stabilized Treated Plant Mix Base Course

    Item 207 Portland Cement Stabilized Treated Plant Mix Base Course

    ユーザ名非公開 · 13問 · 13日前

    Item 207 Portland Cement Stabilized Treated Plant Mix Base Course

    Item 207 Portland Cement Stabilized Treated Plant Mix Base Course

    13問 • 13日前
    ユーザ名非公開

    Item 204 Portland Cement Stabilized Road Mix Base Course

    Item 204 Portland Cement Stabilized Road Mix Base Course

    ユーザ名非公開 · 7問 · 13日前

    Item 204 Portland Cement Stabilized Road Mix Base Course

    Item 204 Portland Cement Stabilized Road Mix Base Course

    7問 • 13日前
    ユーザ名非公開

    Item 202 Crushed Aggregate Base Course

    Item 202 Crushed Aggregate Base Course

    ユーザ名非公開 · 18問 · 13日前

    Item 202 Crushed Aggregate Base Course

    Item 202 Crushed Aggregate Base Course

    18問 • 13日前
    ユーザ名非公開

    問題一覧

  • 1

    Study that concern itself with the physical, chemical, and biological factors which influenced the formulation, manufacture, stability, and effectiveness of pharmaceutical dosage forms

    Pharmaceutics

  • 2

    An agent intended for use in diagnosis, mitigation, treatment, cure, and prevention of disease in man or animal

    Drug

  • 3

    Dosage forms in which drugs are prepared by the pharmacists for administration in the treatment of disease

    Pharmaceutical preaparations

  • 4

    This may be done extemporaneously compounded or manufactured for immediate distribution

    Pharmaceutical preparations

  • 5

    Dosage forms are also known as

    Pharmaceuticals

  • 6

    It is prepared by adding an active ingredient (API / therapeutic ingredients / pharmacological active ingredients ) and a non-therapeutic ingredient (inert or inactive ingredients) which comprises a vehicle or formulation matrix

    Dosage forms

  • 7

    Other term for non-therapeutic / inert / inactive ingredients

    excipients

  • 8

    Means the production, preparation, propagation, conversion, or processing of a drug or device, either directly or indirectly, by extraction from substances of natural origin or independently by means of chemical or biological synthesis

    Manufacturing

  • 9

    Preparation of components into a drug product as the result of a practitioner's prescription drug order based on the practitioner/patient/pharmacist relationship in the course of professional practice

    Compounding

  • 10

    Preparation of components into a drug product for the purpose of, or as an incident to, research, teaching, or chemical analysis and not for sale or dispensing

    Compounding

  • 11

    What compedium chap. 795 stated that compounding is the preparation, mixing, assembling, altering, packaging and labeling of a drug, drug delivery device, or device in accordance with a licensed practitioner’s prescription, medication order, or initiative based on the practitioner-patient-pharmacist-compounder relationship in the course of professional practice

    United States Pharmacopeia

  • 12

    Pharmacists may _____, in reasonable quantities, dmg preparations that are commercially available in the marketplace if a pharmacist-patient-prescriber relationship exists and a valid prescription is presented

    compound

  • 13

    Pharmacists may compound _____ medications in commercially available dosage forms or in alternative dosage forms to accommodate patient needs as allowed by individual state boards of pharmacy

    non prescription

  • 14

    Pharmacists may _____ drugs in limited quantities prior to receiving a valid prescription, on the basis of a history of receiving valid prescriptions that have been generated solely within an established pharmacist-patient–prescriber relationship, and provided that the prescriptions are maintained on file for all such preparations dispensed at the pharmacy

    compound

  • 15

    Pharmacists should not offer _____ medications to other pharmacies for resale; however, a practitioner may obtain compounded medication to administer to patients, but it should be labeled with the following: “For Office Use Only,” date compounded, use-by date, and name, strength, and quantity of active ingredients. An exception to this may be the outsourcing of some compounded preparations by hospitals to contract compounding pharmacies

    compounded

  • 16

    _____ pharmacies and pharmacists may advertise or otherwise promote the fact that they provide prescription compounding services

    Compounding

  • 17

    It is devised to make possible the administration of medication in measured prescribed amount

    Dosage forms

  • 18

    Device that holds a drug and is or may be, in direct contact with the drug

    Containers

  • 19

    In direct contact with the drug at all times; e.g. closure

    Immediate container

  • 20

    It protects the content from extraneous solids and from loss of the article under ordinary conditions of handling, shipment, storage, and distribution

    Well closed container

  • 21

    It protects the contents from contamination by extraneous liquids, solids, or vapors, from loss of the article and from efflorescence, deliquescence, or evaporation under the ordinary or customary conditions of handling, shipment, storage, and distribution, and is caple of tight reclosure

    Tightly closed container

  • 22

    it is impervious to air or any other gas under the ordinary or customary conditions of handling, shipment, storage, and distribution

    Hermetic container

  • 23

    Intended for injection or parenteral preparation

    Hermetic container

  • 24

    Known as unit dosage package

    Single dose container

  • 25

    One that holds a quantity of drug intended and cannot be resealed when opened with assurance that sterility has been maintained

    Single dose container

  • 26

    One that contains more dose of the medication and permits the withdrawal of successive portions without changing the strength or endangering the quality or purity of the remaining portion

    Multiple dose container

  • 27

    Used primarily for liquid dosage forms

    Round bottle

  • 28

    Used for dispensing liquids of low viscosity

    Rx bottle

  • 29

    Used for bulk powders or large quantity of tablets or capsules

    Wide mouth bottle

  • 30

    Used for applying liquid medication to a wound or skin surface

    Application bottle

  • 31

    Used for powders to be applied by sprinkle

    Sifter-top containers

  • 32

    Used for ophtalmic and otic preparation

    Dropper bottle

  • 33

    Used to dispense semi-solid dosage forms (2 answers)

    Ointment jar, Collapsible tube

  • 34

    Used to dispense liquid contents as a mist or foam

    Aerosol container

  • 35

    Labelling includes desired condition to ensure the stability of a pharmaceutical preparation for the period of its intended shelf life

    Storage

  • 36

    Storage condition hot exceeding 8°C

    Cold

  • 37

    Storage condition between 8-15°C

    Cool

  • 38

    Temperature prevailing in working area

    Room temperature

  • 39

    Storage condition between 15-30°C

    Controlled room temp

  • 40

    Storage condition between 30-40°C

    Warm temp

  • 41

    Storage condition above 40°C

    Excessive heat

  • 42

    Refers to the length of time that a drug produced may remain on the pharmacist’s shelf in the original packages and under usual environmental condition

    Shelf life

  • 43

    Retain an acceptable level of its original potency and overall quality

    Shelf life

  • 44

    If storage condition are not met, either physical degradation or chemical deterioration may occur

    Shelf life

  • 45

    Latest date at which the product is expected to be stable physically, chemically, therapeutically, identity, strength, quality, and purity until that date if storage condition are met

    Expiry date / Beyond Use date

  • 46

    Manufacturer's shelf life of solid dosage forms (e.g. tab & cap)

    5 years from the date of preparation

  • 47

    Manufacturer's shelf life of liquid dosage forms

    shorter shelf life

  • 48

    Manufacturer's shelf life of dispersed systems-aerosols, emulsions, and semi-solid (eg. ointments & suppositories)

    shorter shelf life

  • 49

    Extemporaneous compounding shelf life of non-preserved aqueous

    14 days

  • 50

    Extemporaneous compounding shelf life of preserved aqueous

    35 days

  • 51

    Extemporaneous compounding shelf life of nonaqueous dosage forms

    90 days

  • 52

    Extemporaneous compounding shelf life of solid dosage forms

    180 days

  • 53

    Nomenclature of drug's proprietary name

    brand name

  • 54

    Nomenclature of drug's proprietary name

    trade name

  • 55

    Nomenclature of drug's non-proprietary name

    generic name

  • 56

    Uses yellow prescription

    Dangerous drugs

  • 57

    Prohibited and regulated drugs

    Dangerous drugs

  • 58

    Prescription or legend drugs are also called _____ drugs

    ethical

  • 59

    Requires Rx label

    Prescription / Legend drugs

  • 60

    Can be bought w/o prescription

    OTC drugs

  • 61

    Swallowing via mouth

    per oral

  • 62

    Injected into the body

    parenteral

  • 63

    Inserted into the rectum

    rectal

  • 64

    Applied to a certain area of the skin

    topical

  • 65

    Inserted into the vagina

    vaginal

  • 66

    Inhaled through mouth or nose

    inhalation

  • 67

    Under the tongue

    oral-sublingual

  • 68

    Beside the cheek

    oral-buccal

  • 69

    Administered by application to the tongue

    oral-perlingual